Skip to main content
. Author manuscript; available in PMC: 2019 Jan 28.
Published in final edited form as: J Control Release. 2013 Sep 25;172(3):1151–1160. doi: 10.1016/j.jconrel.2013.09.016

Table 2.

Amount of pazopanib recovered from different ocular tissues like retina, choroid–RPE, sclera, vitreous humor, lens, cornea and from nanotubes at the end of 15 days. Mean weights of tissues isolated for drug analysis are reported. Actual tissue weights may be higher due to incomplete isolation of some tissues. Mean tissue weights reported in this table were multiplied by the mean tissue concentrations of pazopanib (µg/g tissue) to obtain total drug amounts in various tissues. Total administered drug dose was 50 µg each in nanotubular and dispersion samples. Data is expressed as mean for n=3.

Sample Average tissue
weight (mg)
Amount of pazopanib after 15 days (µg)

Nanotube Dispersion
Retina 10.72 ± 1.47 1.15 ± 0.06 0.23 ± 0.00
Choroid-RPE 5.05 ± 0.89 0.24 ± 0.04 0.10 ± 0.01
Vitreous 26.82 ± 3.61 0.29 ± 0.01 0.06 ± 0.00
Sclera 12.57 ± 2.23 0.16 ± 0.03 0.04 ± 0.01
Lens 28.46 ± 2.96 0.08 ± 0.01 0.01 ± 0.00
Aqueous Humor 7.01 ± 1.36 0.001 ± 0.00 0.000 ± 0.00
Cornea 4.85 ± 2.56 0.002 ± 0.00 0.000 ± 0.00
Total drug
recovered in all
the ocular
tissues analyzed
2 (4.4 %) 0.45 (0.9%)